Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.730
-0.100 (-2.07%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Whitehawk Therapeutics stock has a consensus rating of "Buy" and an average price target of $7.50. The average 1-year stock price forecast is 58.56% higher than the current stock price, while the lowest is $4.00 (-15.43%) and the highest is $10 (+111.42%).

Price Target: $7.50 (+58.56%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.00$7.50$7.50$10
Change-15.43%+58.56%+58.56%+111.42%

Analyst Ratings

The average analyst rating for Whitehawk Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy222344
Buy011111
Hold333333
Sell000000
Strong Sell000000
Total566788

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Oppenheimer
No rating
Oppenheimer
Buy
Reiterates
$7
BuyReiterates$7+47.99%Aug 7, 2026
TD Cowen
TD Cowen
Hold
Maintains
n/a
HoldMaintainsn/an/aAug 7, 2026
JonesTrading
JonesTrading
Buy
Maintains
$7
BuyMaintains$7+47.99%Aug 7, 2026
Leerink Partners
Leerink Partners
Buy
Initiates
$9
BuyInitiates$9+90.27%Jul 13, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$10
BuyInitiates$10+111.42%Jun 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 7.15M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.97
from -1.74
EPS Next Year
-0.99
from -0.97
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.12M15.22M24.35M25.98M7.15M-
Revenue Growth
-92.32%1,258.57%60.06%6.69%-72.50%-100.00%
Operating Income
-37.06M-58.96M-71.93M-64.82M-114.40M-80.35M
Net Income
-110.09M-60.51M-65.77M-63.69M-20.60M-74.98M
EPS
-----1.74-0.97
Free Cash Flow
-15.23M-29.52M-37.70M-38.69M-53.65M-79.00M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-100.0%
Avg
-100.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-0.90
Avg-0.97
Low-1.03

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-